The rescue experiments indicated PDCD4 can rescue the phenotype by miR-320a gain of function and suggested that miR-320a played its function in drug-resistance of pancreatic cancer cells by targeting PDCD4. Here, PDCD4 is linked to familial pancreatic carcinoma.